Astrea Bioseparations (“Astrea Bio”), a number one supplier of high-quality bioseparation and purification applied sciences, introduced right this moment the acquisition of Delta Precision Ltd. (“Delta Precision”), a premier producer of superior chromatography columns for the biotechnology and pharmaceutical industries.
This strategic acquisition, which follows a long-standing relationship of virtually a decade, will enable Astrea Bio to broaden its product providing to incorporate a full vary of high-performance chromatography columns for biomanufacturing, complementing and strengthening the corporate’s present portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns.
Delta Precision’s merchandise are widely known for his or her high quality, ease of use, and sturdiness, and are utilized in quite a lot of functions, together with protein purification, vaccine manufacturing, and drug growth.
We’re delighted to welcome the Delta staff into the fold. The acquisition of Delta is one other step ahead in Astrea Bio’s fast enlargement to assist the biopharmaceutical manufacturing area. This can be a extremely strategic transfer for us, permitting us to supply a full vary of industry-leading purification and separation instruments.
Terry Pizzie, CEO, Astrea Bio
We sit up for becoming a member of the Astrea Bio household, additional cementing the long-standing relationship between the 2 corporations. We’re assured that our experience in column manufacturing will complement and speed up the Astrea Bio enterprise and buyer attain.
Geoff Parnell, Co-founder and Managing Director at Delta Precision
This acquisition marks a big milestone for Astrea Bioseparations and can enable the corporate to additional speed up new product growth and quickly convey new advances in purification and separation expertise to market.
